Cerebrospinal Fluid Biomarkers in Differential Diagnosis of Multiple Sclerosis and Systemic Inflammatory Diseases with Central Nervous System Involvement
Background: Diagnosis of multiple sclerosis (MS) is established on criteria according to clinical and radiological manifestation. Cerebrospinal fluid (CSF) analysis is an important part of differential diagnosis of MS and other inflammatory processes in the central nervous system (CNS). Methods: In...
Main Authors: | Mariola Świderek-Matysiak, Magdalena Oset, Małgorzata Domowicz, Grażyna Galazka, Magdalena Namiecińska, Mariusz Stasiołek |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-02-01
|
Series: | Biomedicines |
Subjects: | |
Online Access: | https://www.mdpi.com/2227-9059/11/2/425 |
Similar Items
-
Predictive value of brain atrophy, serum biomarkers and information processing speed for early disease progression in multiple sclerosis
by: Magdalena Oset, et al.
Published: (2023-07-01) -
Cholesterol levels in plasma and cerebrospinal fluid in patients with clinically isolated syndrome and relapsing-remitting multiple sclerosis
by: Maria-Eleftheria Evangelopoulos, et al.
Published: (2022-11-01) -
Natalizumab Induces Changes of Cerebrospinal Fluid Measures in Multiple Sclerosis
by: Ranjani Ganapathy Subramanian, et al.
Published: (2021-11-01) -
Cerebrospinal fluid oligoclonal bands in Chinese patients with multiple sclerosis: the prevalence and its association with clinical features
by: Xiang Zhang, et al.
Published: (2023-11-01) -
Cerebrospinal Fluid Analysis in Multiple Sclerosis Diagnosis: An Update
by: Bruna Lo Sasso, et al.
Published: (2019-06-01)